The Biojam Holding Group now has available a rapid test that combines the detection of SARS-CoV-2 and Influenza A and B in 15 minutes in a single procedure, with a single collection and cassette yielding 2 results.
This innovative test brings advantages such as:
- Reducing the risk of error and identification;
- Decreasing the human resources allocated;
- Savings in acquisition (being only one single test);
- Less discomfort for the patient, as only one swab collection is needed;
- Ease of use in a hostile emergency environment;
- Considerable reduction in waste;
- Both results in 15 minutes.